n/a (IRMD)

NasdaqGM: IRMD · Echtzeitkurs · USD

87.40

-0.15 (-0.17%)

Zum Schluss: Aug 19, 2026, 9:39 PM

-0.17% (1D)

Keine Daten verfügbar

Geld	n/a
Marktkapitalisierung	1.12 Mrd
Umsatz (TTM)	n/a
Nettogewinn (TTM)	n/a
Beta	n/a
EPS (ttm)	1.79
KGV (TTM)	48.83
Forward-KGV	n/a
KBV (TTM)	n/a
KUV (TTM)	n/a
Earnings Date	n/a

Brief	n/a
Volumen	99,690
Ø Vol. (20D)	141,106
Eröffnung	n/a
Vortagesschluss	87.55
Tagesspanne	n/a - n/a
52-Wk Range	67.84 - 107.90
Analyst	n/a
Kursziel	n/a
Dividenden	n/a
Ex-Dividenden-Datum	n/a

Über IRMD

A detailed description of the company is not yet available....

[Mehr lesen]

Branche n/a

Sektor n/a

IPO Datum n/a

Mitarbeiter n/a

Börse n/a

Tickersymbol IRMD

Vollständiges Unternehmensprofil

Nachrichten

vor 1 Woche · Motley Fool

IRadimed (IRMD) Q2 2026 Earnings Call Transcript

New 3870 pump production ramp compressed margins but bookings doubled shipments.

vor 1 Woche · Simply Wall St.

How IRADIMED's Modest Q2 Beat and Reaffirmed 2026 Guidance Will Impact IRMD Investors

IRADIMED CORPORATION recently reported past second-quarter 2026 results showing sales of US$20.47 million, slightly higher than a year earlier, alongside lower quarterly net income and earnings per sh...

vor 1 Woche · Insider Monkey

Replacement Cycle Anchors IRadimed Corp.’s (IRMD) Long Term Growth

Conestoga Capital Advisors, an asset management company, released its second-quarter 2026 investor letter. A copy of the letter can be downloaded here. The letter reports a positive market shift towar...

vor 2 Wochen · GuruFocus.com

iRadimed Corp (IRMD) (Q2 2026) Earnings Call Highlights: Strong Demand for New 3,870 Pump ...

iRadimed Corp (IRMD) navigates a pivotal transition quarter with robust bookings for its next-generation MRI pump, offset by near-term margin pressure and flat revenue growth.

vor 2 Wochen · Moby

IRadimed Corporation Q2 2026 Earnings Call Summary

Moby summary of IRadimed Corporation's Q2 2026 earnings call

Seite 1 von 2

n/a (IRMD)

Über IRMD

Gewinnüberraschung

Why Price Moved